These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6496369)

  • 21. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM; Granrud G; Sharkey P; Asinger R; Hodges M
    Am J Cardiol; 1984 Jan; 53(1):77-83. PubMed ID: 6362387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
    Korsukewitz J; Wegscheider K; Schmutzler H
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1103-7. PubMed ID: 2408842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T; Podrid PJ; Raeder E; Lown B
    Am J Cardiol; 1986 Aug; 58(5):87C-95C. PubMed ID: 3092625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
    Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Propafenone, a new anti arrhythmic agent].
    Ruipérez Abizanda JA; Campos Peris JV; Ruiz Ros JA; García García J; Jaen Armand E; Marco Quiles J; Martínez Jerez M; Salas Nieto J; Rodríguez Ruiz P; Pico Aracil F
    Rev Clin Esp; 1980 Sep; 158(6):279-81. PubMed ID: 7010468
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia.
    Mitchell LB; Duff HJ; Manyari DE; Wyse DG
    N Engl J Med; 1987 Dec; 317(27):1681-7. PubMed ID: 3320747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR; Loogen F
    Eur Heart J; 1980 Feb; 1(1):11-24. PubMed ID: 7026245
    [No Abstract]   [Full Text] [Related]  

  • 40. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M; Steinbeck G; Lüderitz B
    Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.